TY - JOUR
T1 - Using solution X-ray scattering to determine the high-resolution structure and morphology of PEGylated liposomal doxorubicin nanodrugs
AU - Schilt, Y.
AU - Berman, T.
AU - Wei, X.
AU - Barenholz, Y.
AU - Raviv, U.
N1 - Publisher Copyright:
© 2015 Published by Elsevier B.V.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Background Among nanodrugs, PEGylated nanoliposomes loaded with an active agent are of major importance. In this paper we studied the structures and morphology of PEGylated nanoliposomes before and after remote loading with doxorubicin. Methods High-resolution structures were obtained by solution X-ray scattering combined with our advanced analysis tools. We studied the PEGylated liposomal doxorubicin (PLD) product Doxil®, and its generics, where remote doxorubicin loading is performed by a gradient of ammonium sulfate, and LC100, a novel PLD under development, where remote loading was done by a gradient of ammonium methanesulfonate. The PLD structures were compared with drug-free nanoliposomes having identical composition. Results We determined the membrane electron density profiles of the empty and loaded PLDs, the thickness and density of the PEG layers, and the structure of the drug inside the liposomes. Conclusions The liposomal membranes had the same structure for both ammonium salts. We found that the drug formed crystals inside PLDs loaded by ammonium sulfate, whereas it had an amorphous morphology in the PLD loaded by ammonium methanesulfonate. The variations of the drug's structural parameters between the generics of Doxil® are similar to the variations between batches of the same product, suggesting that all these products were structurally similar. General significance This paper demonstrates that solution X-ray scattering, when combined with our powerful analysis tools, can determine the high-resolution structure of complex non-crystallized nanoparticle dispersions used in nanomedicine, thereby providing useful physical insights into their functions.
AB - Background Among nanodrugs, PEGylated nanoliposomes loaded with an active agent are of major importance. In this paper we studied the structures and morphology of PEGylated nanoliposomes before and after remote loading with doxorubicin. Methods High-resolution structures were obtained by solution X-ray scattering combined with our advanced analysis tools. We studied the PEGylated liposomal doxorubicin (PLD) product Doxil®, and its generics, where remote doxorubicin loading is performed by a gradient of ammonium sulfate, and LC100, a novel PLD under development, where remote loading was done by a gradient of ammonium methanesulfonate. The PLD structures were compared with drug-free nanoliposomes having identical composition. Results We determined the membrane electron density profiles of the empty and loaded PLDs, the thickness and density of the PEG layers, and the structure of the drug inside the liposomes. Conclusions The liposomal membranes had the same structure for both ammonium salts. We found that the drug formed crystals inside PLDs loaded by ammonium sulfate, whereas it had an amorphous morphology in the PLD loaded by ammonium methanesulfonate. The variations of the drug's structural parameters between the generics of Doxil® are similar to the variations between batches of the same product, suggesting that all these products were structurally similar. General significance This paper demonstrates that solution X-ray scattering, when combined with our powerful analysis tools, can determine the high-resolution structure of complex non-crystallized nanoparticle dispersions used in nanomedicine, thereby providing useful physical insights into their functions.
KW - Drug delivery
KW - Generic drugs
KW - Liposomal doxorubicin
KW - PEGylated liposomes
KW - SAXS
KW - WAXS
UR - http://www.scopus.com/inward/record.url?scp=84946222927&partnerID=8YFLogxK
U2 - 10.1016/j.bbagen.2015.09.012
DO - 10.1016/j.bbagen.2015.09.012
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 26391840
AN - SCOPUS:84946222927
SN - 0304-4165
VL - 1860
SP - 108
EP - 119
JO - Biochimica et Biophysica Acta - General Subjects
JF - Biochimica et Biophysica Acta - General Subjects
IS - 1
ER -